Compare ARK Genomic Revolution ETF (ARKG) vs FedEx Corporation (FDX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs FedEx Corporation — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while FedEx Corporation trades at $314.69 (market cap $75.09B). The key difference: FedEx Corporation pays a 1.55% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | FDX | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $338.75 |
52-Week Low | $23.09 | $174.81 |
Market Cap | — | $75.09B |
Enterprise Value | — | $104.72B |
Dividend Yield | — | 1.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FedEx (FDX) trades at $314.69, up 1.24% on the day, with a bearish technical signal from moving averages but oversold RSI levels. Recent earnings have consistently beaten estimates, with Q1 2026 EPS of $6.31 exceeding expectations. The company is executing strategic moves, including the sale of its supply chain unit to CMA CGM for $1.4 billion and a $4.15 billion debt tender offer to reduce leverage. Fundamentals show stable revenue near $88 billion and a net income margin of 4.68%, though operating cash flow declined to $7.04 billion in 2025.
The outlook is mixed; analyst consensus is bullish with a $365.73 price target, but margin recovery remains uncertain amid competitive pressures from Amazon Logistics. Risks include soft shipping demand and ongoing cost-cutting needs. The stock offers value with a P/E of 16.97, but investors should monitor execution of efficiency initiatives and freight segment performance post-spinoff.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →
